Medicines

Everything here about the medicines used for Crohn's in general: our articles first, then short answers, the words you may hear, and the original sources.

Articles

Common questions 11

Can ibuprofen affect a calprotectin test?

Yes. An NHS hospital leaflet says anti-inflammatory painkillers (NSAIDs) such as ibuprofen, naproxen and diclofenac can affect the result. Ask the doctor who requested the test whether you should stop them beforehand, and do not stop any prescribed medicine without advice. Crohn's & Colitis UK also notes that NSAIDs may make Crohn's symptoms worse in some people.

Sources

What should I do if I'm planning a pregnancy?

Speak to your IBD team before trying, ideally while your Crohn's is in remission. The NHS and Crohn's & Colitis UK both say some medicines need changing before or during pregnancy. Methotrexate, for example, must be stopped well in advance, by men as well as women, while many others are continued. The charity says some people need a higher dose of folic acid, such as those with small bowel Crohn's or on sulfasalazine. Bumps has leaflets on individual medicines in pregnancy.

Sources

Can I breastfeed while taking Crohn's medicines?

Often, yes. The NHS says only small amounts of most medicines pass into breast milk and very few are unsafe. Crohn's & Colitis UK says most biologics are thought to be compatible with breastfeeding, but the advice differs between medicines, so check with your IBD team first. If you took immune-lowering medicines in pregnancy, your baby's live vaccines may need delaying, so tell the baby's healthcare team.

Sources

What does 'treat to target' mean?

It means your team agrees goals in advance and adjusts treatment until you reach them, rather than waiting for symptoms. The STRIDE-II expert agreement says early goals are feeling better and getting blood and poo inflammation tests back to normal; longer-term goals are a healed bowel lining, no disability, good quality of life and normal growth in children. The CALM trial found that stepping up treatment when tests showed inflammation, not just when symptoms flared, led to more bowel healing.

Sources

Which painkillers should I avoid with Crohn's and bleeding?

The NHS Crohn's page says not to take non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen unless a doctor recommends them. The NHS piles page says not to take ibuprofen if your piles are bleeding, and to avoid codeine painkillers because they can cause constipation. Ask a pharmacist or your IBD team which pain relief is suitable for you.

Sources

Can I take anti-diarrhoea medicine during a flare?

Crohn's & Colitis UK advises not taking anti-diarrhoea (antimotility) medicines if you are in a flare, have a high temperature or have blood in your poo, because of the risk of a serious complication called toxic megacolon. It also says you may not be able to take them if you have a stricture. Check with your pharmacist or IBD team first.

Source

What are the main treatments for Crohn's disease?

The NHS explains there is no cure yet, but treatments can control symptoms and keep the disease quiet. NICE describes treatment in two stages: bringing a flare under control (often with steroids) and keeping it under control afterwards (for example with immunosuppressants or biologics). Liquid-only diets are an option, especially for children, and surgery may help when only part of the gut is affected or medicines are not working. Your IBD team will tailor the plan to you.

Sources

What is the difference between 'step-up' and 'top-down' treatment?

Step-up means starting with simpler treatments such as steroids and only moving on to stronger medicines if those do not work. Top-down means starting a biologic early, usually infliximab together with an immunomodulator. The UK PROFILE trial found that, in newly diagnosed people with active Crohn's, top-down treatment led to far more steroid-free and surgery-free remission after a year, and fewer hospital stays and complications after five years. The 2025 BSG guideline now suggests early infliximab for moderate to severe Crohn's.

Sources

Which biologics and targeted medicines are approved for Crohn's on the NHS?

NICE has approved infliximab and adalimumab (TA187), vedolizumab (TA352), ustekinumab (TA456), risankizumab (TA888), upadacitinib (TA905), mirikizumab (TA1080) and guselkumab (TA1095) for Crohn's, each under certain conditions. Most of the newer ones are for people whose disease has not responded to, or cannot have, an earlier treatment. Your IBD team decides with you which is suitable.

Sources

What is upadacitinib (Rinvoq) and how is it different from biologics?

Upadacitinib is a tablet that belongs to a group called JAK inhibitors. It blocks proteins inside cells that switch on the immune response, rather than being an antibody given by drip or injection. Trials found it worked better than placebo for moderate to severe Crohn's, and NICE recommends it after a biologic has failed or when anti-TNFs are unsuitable. Shingles was more common in people taking it.

Sources

Do antibiotics treat Crohn's disease itself?

A Cochrane review found any benefit of antibiotics for active Crohn's is probably small. Antibiotics are mainly used for complications, such as infections, abscesses and fistulas, according to Crohn's & Colitis UK. NICE suggests metronidazole for up to three months alongside azathioprine after some bowel operations to help keep Crohn's from returning.

Sources

Words you might hear 18

Adverse event
Any unwanted health problem that happens during a trial, whether or not the treatment caused it. A 'serious adverse event' is one that is life-threatening or leads to hospital.
Aminosalicylate
An anti-inflammatory medicine more often used in ulcerative colitis. NICE says it is less effective than steroids in Crohn's.
Antibiotics
Medicines that kill bacteria. In Crohn's they are mainly used for complications such as abscesses and fistulas.
Bile acid binders
Medicines that stick to bile acids in the gut so they cannot irritate the colon, used to treat bile acid diarrhoea.
Induction
The first phase of treatment, aimed at bringing a flare under control. Often uses higher or more frequent doses.
Induction of remission
The first stage of treatment, aimed at calming a flare and getting Crohn's under control.
Jak inhibitor
A tablet that blocks JAK proteins inside cells, which help switch on the immune response.
Maintenance
Ongoing treatment given after a flare has settled, to keep the disease quiet and stop it coming back.
Maintenance of remission
The longer-term stage of treatment, aimed at keeping Crohn's quiet once a flare has settled.
Nice technology appraisal
NICE's decision on whether a specific medicine should be available on the NHS in England.
Nsaids
Anti-inflammatory painkillers such as ibuprofen, naproxen and high-dose aspirin. The NHS advises people with Crohn's not to take them unless a doctor recommends it.
Refractory
Describes disease that has not responded to standard treatments.
Small molecule
A newer type of Crohn's medicine taken as a tablet that works inside cells to calm inflammation, such as upadacitinib.
Step-up treatment
Starting with milder medicines and moving on to stronger ones only if the milder ones do not work.
Sulfasalazine
An older 5-ASA medicine. Crohn's & Colitis UK says it can lower sperm count and movement while it is taken, which usually recovers 2 to 3 months after stopping. People taking it may be advised to have a higher dose of folic acid in pregnancy.
Top-down treatment
Starting strong treatment such as a biologic, often with an immunosuppressant, soon after diagnosis, instead of trying milder medicines first.
Treat to target
An approach where treatment is adjusted until measured goals are met, such as normal calprotectin or a healed gut lining, rather than only until symptoms improve.
Upadacitinib
A daily JAK-inhibitor tablet used for moderate to severe Crohn's when other advanced treatments have not worked or are unsuitable.

Further reading 53

The original NHS, NICE, charity and research pages on this topic, with our summary of each.

Guides for patients and families

Web pages 13

Breastfeeding and medicines

NHS Web page May 2026 For patients

The NHS says only very small amounts of most medicines pass into breast milk and very few are unsafe while breastfeeding. It advises always telling your GP, midwife, health visitor or pharmacist that you are breastfeeding when a medicine is discussed.

Topics Pregnancy and fertility Medicines

Jargon explained breastfeeding

Steroids

NHS Web page Jun 2025 For patients

A general NHS explainer on steroid medicines (corticosteroids), which mimic hormones the body makes and reduce inflammation. It lists Crohn's disease among the conditions treated, explains the different forms steroids come in, and covers common side effects.

Topics Steroids Medicines

Jargon explained corticosteroids anabolic steroids

About methotrexate

NHS Web page Mar 2023 For patients

The NHS introduction to methotrexate, an immunosuppressant used for Crohn's disease, arthritis and psoriasis. It explains the forms it comes in, that it is taken once a week for these conditions, and why you carry a patient card and need to take care with infections and vaccines.

Topics Immunosuppressants Medicines

Jargon explained immunosuppressant inflammation

Side effects of methotrexate

NHS Web page Mar 2023 For patients

The NHS list of common and serious methotrexate side effects, with tips for coping with sickness, diarrhoea and tiredness. It explains which warning signs of liver, lung, kidney, blood or infection problems need urgent advice, and notes sun sensitivity and possible long-term liver or lung effects.

Topics Immunosuppressants Medicines

Jargon explained anaphylaxis sun sensitivity

Take medicine in or out of the UK

GOV.UK Web page For patients

Government rules on carrying medicines into and out of the UK. It advises asking your doctor or pharmacist whether a medicine is a controlled drug, explains when you need a prescription or a letter from your doctor as proof the medicine is yours, and says to check the rules of the country you are visiting.

Topics Travel Medicines

Jargon explained controlled drugs

Biosimilar medicines

NHS England Web page Patients and professionals

NHS England's page on biosimilars: biological medicines shown to have no meaningful differences in quality, safety or effectiveness from the original brand. It explains why the NHS encourages their use, that switching between the original and a biosimilar is now accepted practice, and how savings are reinvested.

Topics Biologics and newer medicines Medicines

Jargon explained biosimilar originator medicine switching

Azathioprine: a medicine to treat autoimmune conditions

NHS Web page Oct 2026 For patients

NHS medicine guide to azathioprine. It lists skin becoming more sensitive to sunlight as a common side effect, says it may not suit people recently given a live vaccine such as chickenpox or yellow fever, and says it can be used in pregnancy if a specialist recommends it, pointing to the Bumps website for more.

Topics Immunosuppressants Cancer risk and screening Pregnancy and fertility Medicines

Jargon explained azathioprine thiopurine live vaccine immunosuppressant DMARD bone marrow

Crohn's disease

NHS Web page Dec 2023 For patients

The NHS overview of Crohn's: a lifelong condition where part of the gut becomes inflamed, with no cure yet but treatments that can control it. It lists the usual symptoms, explains that symptoms come and go in flare-ups and remissions, and says there is no single test, so diagnosis usually involves blood and poo tests from the GP followed by camera tests, biopsies and scans in hospital. It also covers possible causes (genes, smoking, a recent stomach bug, recent appendix removal) and when to get urgent help.

Topics About Crohn's disease Symptoms Diagnosis and tests Flare-ups Diet and nutrition Pregnancy and fertility Living well Complications Medicines Surgery

Jargon explained inflammation flare-up remission colonoscopy endoscopy biopsy fistula stricture gastroenterologist inflammatory bowel disease anal fissure perforation nsaids biologics stoma

Leaflets 2

Managing a Crohn's or colitis flare-up

West Hertfordshire Teaching Hospitals NHS Trust Leaflet For patients

A hospital self-management leaflet that helps you decide whether you are having a flare and lists signs of a severe attack that mean contacting your GP urgently or going to urgent care or the emergency department. It also describes which medicine changes some patients may make themselves and which must only be changed by the IBD team; follow your own team's plan.

Topics Flare-ups Urgent help Medicines

Jargon explained flare-up acute severe ulcerative colitis crp

Guides 10

Steroids

Crohn's & Colitis UK Guide Aug 2026 For patients

The charity's guide to steroids for Crohn's and Colitis, covering prednisolone, budesonide (brands such as Budenofalk and Entocort) and other forms. It explains side effects, why steroids are only for short-term use, why you must never stop suddenly, how the dose is gradually reduced, the risk of adrenal insufficiency, and carrying a steroid card.

Topics Steroids Medicines

Jargon explained corticosteroids budesonide tapering adrenal insufficiency steroid card

Pregnancy and birth

Crohn's & Colitis UK Guide Aug 2025 For patients

Guides people through planning a pregnancy and giving birth with Crohn's or Colitis. It explains why being in remission matters, which tests and medicines are considered safe in pregnancy (and which, like methotrexate, must be stopped well beforehand), and that a higher dose of folic acid may be advised for some people, such as those with small bowel Crohn's or on sulfasalazine. It also covers birth choices, including when a caesarean may be recommended.

Topics Pregnancy and fertility Medicines

Jargon explained remission folic acid caesarean section methotrexate

Postnatal care and breastfeeding

Crohn's & Colitis UK Guide Aug 2025 For patients

Covers looking after yourself after birth and deciding whether breastfeeding is right for you while on Crohn's medicines. It says most biologics are thought to be compatible with breastfeeding, but advice varies by medicine. If you took immune-lowering medicines during pregnancy, your baby's live vaccines may need to be delayed, so tell the baby's healthcare team. Non-live vaccines are thought to be safe.

Topics Pregnancy and fertility Medicines Vaccinations and infections

Jargon explained breastfeeding biologics live vaccine postnatal

Biologic medicines and other targeted treatments

Crohn's & Colitis UK Guide Jul 2023 For patients

An overview of biologics and other targeted medicines for Crohn's and Colitis, with a table of each medicine, its brand names and how it works. It explains that biologics are lab-made antibodies given by drip or injection, and covers biosimilars, anti-TNFs, interleukin inhibitors and JAK inhibitors.

Topics Biologics and newer medicines Medicines

Jargon explained biologic biosimilar anti-TNF IL-23 inhibitor JAK inhibitor advanced therapy

Methotrexate

Crohn's & Colitis UK Guide Mar 2023 For patients

The charity's guide to methotrexate for Crohn's and Colitis, available as tablets or injections (brands include Metoject and Nordimet). It explains how it works, what trials showed, that it can be given alongside a biologic to reduce the antibodies the body makes against it, and the monitoring needed.

Topics Immunosuppressants Medicines

Jargon explained immunosuppressant antibodies subcutaneous injection

Diarrhoea

Crohn's & Colitis UK Guide Dec 2023 For patients

Covers why diarrhoea happens in Crohn's and Colitis, including inflammation and bile acid malabsorption after the end of the small bowel is inflamed or removed, which can also cause greasy, floating poo. Warns not to take anti-diarrhoea medicines during a flare, with a temperature or with blood in your poo because of the risk of toxic megacolon, and explains bile acid binders.

Topics Toilet habits Symptoms Medicines

Jargon explained bile acid malabsorption steatorrhoea toxic megacolon bile acid binders stricture

Tools 1

Systematic reviews 5

Antibiotics for induction and maintenance of remission in Crohn's disease

Cochrane Systematic review Feb 2019 Patients and professionals

Antibiotics may give a small benefit for active Crohn's, but probably not enough to make a real difference for most people. They did not cause more side effects than placebo. Whether they help keep Crohn's in remission is unclear. Note this is about treating the Crohn's itself, not infections or abscesses.

Topics Medicines Research

Jargon explained antibiotic clinically meaningful antibiotics induction maintenance

Aminosalicylates for induction of remission or response in Crohn's disease

Cochrane Systematic review Jul 2016 Patients and professionals

Mesalazine-type drugs (aminosalicylates) are widely used for ulcerative colitis, but this review found little evidence that they work for active Crohn's. Low and high doses of mesalazine were not clearly better than placebo. Some trials comparing high-dose mesalazine with budesonide gave mixed results.

Topics Medicines

Jargon explained aminosalicylate 5-ASA mesalazine

Interventions for maintenance of surgically induced remission in Crohn's disease: a network meta-analysis

Cochrane Systematic review Sep 2019 Patients and professionals

Compares the medicines used to stop Crohn's returning after an operation. The evidence was not strong enough to say which works best. Cases of pancreatitis and low white blood cell counts were seen with azathioprine-type drugs.

Topics Surgery Medicines

Jargon explained network meta-analysis endoscopic relapse postoperative recurrence

Studys 1

Upadacitinib Induction and Maintenance Therapy for Crohn's Disease (U-EXCEL, U-EXCEED, U-ENDURE)

New England Journal of Medicine Study May 2023 Patients and professionals

Three trials of upadacitinib (Rinvoq), a daily tablet rather than an injection or drip. It worked better than placebo both for settling active Crohn's over 12 weeks and for keeping it settled over a year. Some side effects, such as liver changes, low white cells and a few cases of bowel perforation, were seen more on the drug, so it needs monitoring.

Topics Medicines Immunosuppressants Research

Jargon explained JAK inhibitor small molecule induction maintenance herpes zoster endoscopic response

For health professionals

Guidelines 18

British Society of Gastroenterology guidelines on inflammatory bowel disease in adults: 2025

British Society of Gastroenterology (Gut) Guideline Jun 2025 For professionals

The UK specialists' full guideline for managing Crohn's and ulcerative colitis in adults, free to read. Beyond medicines and surgery, it covers special situations such as pregnancy and problems outside the gut. Written for clinicians, but useful background for patients who want the detail behind their care.

Topics Medicines Pregnancy and fertility Beyond the gut

Jargon explained guideline network meta-analysis extraintestinal manifestations

ACG Clinical Guideline: Management of Crohn's Disease in Adults

American College of Gastroenterology (Am J Gastroenterol) Guideline Jun 2025 For professionals

The American College of Gastroenterology's 2025 update on diagnosing and treating Crohn's in adults, replacing its 2018 guideline. It reflects how much treatment has changed in recent years. Like other US guidance, it is a useful comparison to UK practice rather than a guide to what the NHS offers.

Topics Medicines Diagnosis and tests Research

Jargon explained idiopathic etiology

ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment

European Crohn's and Colitis Organisation (J Crohns Colitis) Guideline Oct 2024 For professionals

Europe's main expert guideline on which medicines to use for Crohn's disease, published as the first of a two-part set (the second covers surgery). It weighs up the trial evidence for steroids, immunosuppressants, biologics and newer tablets, including treatment of disease around the back passage. UK specialists use it alongside the BSG guideline.

Topics Medicines Biologics and newer medicines Immunosuppressants Around the bottom (perianal)

Jargon explained biologic immunomodulator induction maintenance de-escalation perianal fistula GRADE

AGA Clinical Practice Guidelines on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn's Disease

American Gastroenterological Association (Gastroenterology) Guideline Jun 2021 For professionals

The American Gastroenterological Association's guideline on medicines for moderate to severe Crohn's, including fistulas around the anus. It rates the strength of evidence behind each drug option. It is American, so some drug choices and approvals differ from the NHS, but it is free to read in full and widely cited.

Topics Medicines Biologics and newer medicines Around the bottom (perianal)

Jargon explained luminal perianal fistulizing certainty of evidence

Guselkumab for previously treated moderately to severely active Crohn's disease (TA1095)

NICE Guideline Aug 2025 For professionals

NICE's appraisal allowing guselkumab (Tremfya) for adults with moderate to severe Crohn's disease when earlier treatment has not worked or cannot be tolerated and an anti-TNF medicine is not working or unsuitable. It asks clinicians to choose the least expensive of the suitable options, which include guselkumab, risankizumab and vedolizumab.

Topics Biologics and newer medicines Medicines

Jargon explained IL-23 inhibitor TNF-alpha inhibitor conventional treatment

British Society of Gastroenterology guidelines on inflammatory bowel disease in adults: 2025

British Society of Gastroenterology (Gut) Guideline Jun 2025 For professionals

The 2025 update of the UK specialist guideline for adults with Crohn's or colitis, replacing the 2019 version. It is designed to sit alongside the IBD UK Standards and to encourage GPs to use the national referral pathway for bowel symptoms, so people get diagnosed sooner and more accurately. It was written without drug-company funding and is aimed mainly at the UK, though it can be used elsewhere.

Topics Research Medicines Diagnosis and tests Monitoring

Jargon explained guideline primary care diagnostic pathway

The Medical Management of Paediatric Crohn's Disease: an ECCO-ESPGHAN Guideline Update

ECCO and ESPGHAN (J Crohns Colitis) Guideline Feb 2021 For professionals

European children's gut specialists agreed how to treat Crohn's in children and teenagers. A key message is to spot early the children most likely to have a difficult course, such as those with disease around the bottom or narrowing or penetrating disease, so stronger treatment can start early and limit long-term bowel damage.

Topics Children and young people Medicines Diet and nutrition Biologics and newer medicines

Jargon explained paediatric penetrating disease stricturing disease exclusive enteral nutrition anti-TNF immunomodulator therapeutic drug monitoring

Crohn's disease: management (NG129)

NICE Guideline May 2019 For professionals

NICE's guideline for the NHS in England on managing Crohn's in children, young people and adults. It covers giving people information and support, treatment to bring Crohn's under control and keep it there, surgery, keeping remission after surgery, checking bone health, and pregnancy. It is about care after diagnosis rather than how Crohn's is diagnosed.

Topics About Crohn's disease Medicines Surgery Monitoring Pregnancy and fertility Children and young people Steroids Immunosuppressants

Jargon explained remission inducing remission maintaining remission osteopenia NICE guideline induce remission maintain remission glucocorticosteroid thiopurine TPMT resection stricture

Ustekinumab for moderately to severely active Crohn's disease after previous treatment (TA456)

NICE Guideline Jul 2017 For professionals

NICE's appraisal recommending ustekinumab (Stelara) for adults with moderate to severe Crohn's disease when standard treatment or an anti-TNF medicine has not worked, stopped working or cannot be used. It says the choice between biologics should be made with the patient, using the cheapest suitable option.

Topics Biologics and newer medicines Medicines

Jargon explained interleukin inhibitor TNF-alpha inhibitor biological therapy

Vedolizumab for treating moderately to severely active Crohn's disease after prior therapy (TA352)

NICE Guideline Aug 2015 For professionals

NICE's appraisal recommending vedolizumab (Entyvio) for adults with moderate to severe Crohn's disease when an anti-TNF medicine has failed, stopped working or is unsuitable. It is given as a planned course and reassessed at 12 months.

Topics Biologics and newer medicines Medicines

Jargon explained anti-TNF TNF-alpha inhibitor patient access scheme moderately to severely active

Infliximab and adalimumab for the treatment of Crohn's disease (TA187)

NICE Guideline May 2010 For professionals

NICE's appraisal approving infliximab and adalimumab on the NHS for adults with severe active Crohn's disease when standard treatments such as steroids or immunosuppressants have not worked or cannot be used. It applies to biosimilar versions too, and says treatment should be reviewed at least every 12 months to decide whether to continue.

Topics Biologics and newer medicines Medicines

Jargon explained anti-TNF biosimilar conventional therapy severe active Crohn's disease

British Society of Gastroenterology guidelines on inflammatory bowel disease in adults: 2025

British Society of Gastroenterology Guideline Jun 2025 For professionals

The current UK specialist guideline for managing IBD in adults, replacing the 2019 version. It is designed to sit alongside the IBD Standards and encourage use of the national primary care pathway for lower gut symptoms so diagnosis is quicker and more accurate. Among its general principles, it recommends classifying Crohn's using the Montreal system.

Topics About Crohn's disease Diagnosis and tests Medicines Monitoring Complications Surgery

Jargon explained Montreal classification remission endoscopic remission inflammatory bowel disease advanced therapy GRADE induction maintenance

STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD)

Gastroenterology Guideline Apr 2021 For professionals

An international expert agreement on what 'treat to target' should aim for in IBD. Short-term goals are feeling better and getting blood and poo inflammation tests back to normal. Long-term goals include a healed bowel lining seen at endoscopy, no disability, a normal quality of life, and normal growth in children. Healing through the full bowel wall in Crohn's is not yet a formal target but is a sign of deeper remission.

Topics Monitoring Research Medicines

Jargon explained treat to target endoscopic healing transmural healing biomarker calprotectin CRP clinical remission

Crohn's disease: management - Recommendations

NICE Guideline May 2019 For professionals

The full list of NICE recommendations. It says a standard steroid is usually the first option for a first flare, budesonide or a 5-ASA may be considered for some people who cannot take standard steroids, and liquid feeds may be considered for children worried about growth. It asks for a TPMT check before azathioprine or mercaptopurine, suggests azathioprine with a short course of metronidazole after a complete ileocolonic resection, and says surgery can be considered early when the disease is limited to the end of the small bowel.

Topics Steroids Immunosuppressants Surgery Medicines

Jargon explained TPMT budesonide aminosalicylate enteral nutrition ileocolonic resection metronidazole balloon dilation distal ileum

British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults

Gut (BMJ) via PubMed Central Guideline Sep 2019 For professionals

The free full text of the 2019 BSG guideline, written with surgeons, specialist nurses, dietitians, radiologists, GPs and Crohn's & Colitis UK. It reviewed a very large body of research to make recommendations for adults with IBD. It has been replaced by the 2025 guideline but is a freely readable reference on diagnosis and assessment.

Topics About Crohn's disease Diagnosis and tests Monitoring Research Medicines Surgery

Jargon explained inflammatory bowel disease consensus guideline IBD

Systematic reviews 1

Guides 1

Guideline review: 2025 British Society of Gastroenterology guidelines on inflammatory bowel disease in adults - Part 1: Crohn's disease

Frontline Gastroenterology (via PMC) Guide Nov 2025 For professionals

A readable summary of what the 2025 BSG guideline says about Crohn's. Key points: early 'top-down' infliximab with an immunomodulator for moderate to severe disease; avoiding long or repeated steroid courses; no longer suggesting immunomodulators alone; upadacitinib and risankizumab added; vedolizumab no longer routinely suggested; drug-level testing for anti-TNFs; early surgery as an option for limited ileocaecal disease; and offering early treatment after resection.

Topics Medicines Surgery Monitoring

Jargon explained top-down step-up therapeutic drug monitoring ileocaecal resection Rutgeerts score immunogenicity

Web pages 1